WGWenhao Guo

Wenhao Guo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wenhao Guo has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Jiaxin Jin

    Department of Orthopedics, The Second Hospital of Lanzhou University, The Second Clinical Medical School, Gansu Provincial Bone and Joint Research Institute, Lanzhou University, Lanzhou 730030, China

    2 shared publications
  • Junxu Zhu

    Department of Orthopedics, The Second Hospital of Lanzhou University, The Second Clinical Medical School, Gansu Provincial Bone and Joint Research Institute, Lanzhou University, Lanzhou 730030, China

    2 shared publications
  • Zongyan Cai

    Department of Orthopedics, The Second Hospital of Lanzhou University, The Second Clinical Medical School, Gansu Provincial Bone and Joint Research Institute, Lanzhou University, Lanzhou 730030, China

    2 shared publications
  • Siying Dong

    Second Clinical Medical College, Lanzhou University, Lanzhou 730000, China

    1 shared publication
  • Tao Shen

    Second Clinical Medical College, Lanzhou University, Lanzhou 730000, China

    1 shared publication
  • Tao Shen

    Department of Orthopedics, The Second Hospital of Lanzhou University, The Second Clinical Medical School, Gansu Provincial Bone and Joint Research Institute, Lanzhou University, Lanzhou 730030, China

    1 shared publication

Latest Publications

  • Open Access

    Barrier-Guided Local Nanopharmaceutics for Cartilage and Osteochondral Regeneration: From Effective Tissue Exposure to Cell-State Control and Translational Quality Attributes

    by Tao Shen, Junxu Zhu, Zongyan Cai, Wenhao Guo, Jiaxin Jin

    Local nanopharmaceutic systems are increasingly used to prolong intra-articular residence, improve cartilage access, control local release, and regulate repair-relevant cell states. However, joint retention is often mistaken for effective tissue exposure, and nanoscale complexity is frequently treated as an advantage without demonstrating which transport, biological, or mechanical barrier it resolves. This narrative review develops a barrier-guided framework for nanocarriers, nano-enabled hydrogels, extracellular vesicles, and spatial osteochondral constructs. We distinguish nominal formulation identity from the delivered material state that emerges after dilution, protein adsorption, mechanical loading, and degradation, and we separate joint-cavity persistence, cartilage partitioning and penetration, and bioavailable cargo at target cells. The evidence is strongest when a controllable material attribute is linked to a depth-resolved exposure or repair function; it remains uneven for coupled loading–release behavior, direct cross-platform comparisons, and transferable acceptance limits. We therefore distinguish published quantitative anchors from product-specific specifications and propose a staged workflow that defines two-sided failure boundaries for size and dispersity, binding–dissociation kinetics, stress relaxation, dose, and potency. Across platforms, the practical priorities are reversible rather than maximal binding, matched static-versus-loaded release testing, mechanism-necessity controls for extracellular vesicles, modality-aware fate measurements, and critical quality attributes linked to in vivo performance. The most credible strategy is the minimum necessary complexity that preserves a measurable structure–property–exposure–function relationship from manufacture through remodeling.

  • Open Access

    Attapulgite Nanocomposites for Cartilage and Osteochondral Repair: Material–Tissue Matching, Evidence-Graded Mechanisms and Translation

    by Junxu Zhu, Tao Shen, Siying Dong, Zongyan Cai, Wenhao Guo, Jiaxin Jin

    Attapulgite (ATP; palygorskite) is a fibrous magnesium aluminum silicate that can reinforce hydrated polymer networks, provide a surface for molecular interactions, and participate in formulation-dependent ion or drug delivery. Although ATP has been studied most extensively in bone-oriented composites, its more distinctive role in cartilage repair may be as a spatially controlled regulator of the scaffold microenvironment rather than as a uniformly distributed bioactive filler. This review therefore examines ATP from a cartilage-first perspective. Direct ATP evidence, effects of modified ATP, performance of complete drug-loaded formulations, and cross-material extrapolations are considered separately. Current cartilage data support injectability, shear-thinning, photocrosslinking, mechanical reinforcement, and sustained intra-articular delivery but do not yet establish durable hyaline cartilage regeneration. In osteochondral constructs, ATP is more plausibly restricted to the calcified-cartilage interface or subchondral region, where reinforcement and mineral-associated functions may be beneficial, while high or uniform cartilage-side loading could increase stiffness, hypertrophy, or ectopic mineralization. This interpretation leads to testable design rules: define the ATP material fingerprint, map dose and spatial distribution, distinguish the true carrier phase, and assess cartilage matrix quality, lubrication, anti-hypertrophic stability, interface mechanics, persistence, and synovial safety. ATP should thus be developed as a dose-controlled and spatially restricted component whose value depends on material–tissue matching and direct mechanistic validation.